Use of a Clinical Trial Screening Tool to Address Barriers to Clinical Trial Accrual in the NCI Community Oncology Research Program (NCORP)
Study Number: DCP-001
Study Summary:
Phase I study to evaluate safety and systemic immunogenicity of the DCP-001 vaccine in patients with high grade serous ovarian cancer after primary treatment.
Status: Open
Study Coordinator(s)
- Navigator Courtney, 309-243-3660 cbrown@illinoiscancercare.com
- Erica, 309-243-3626 eraynor@illinoiscancercare.com
- Jess, 309-243-3603 jcallais@illinoiscancercare.com
